Skip to main content
. 2014 May 15;14:335. doi: 10.1186/1471-2407-14-335

Table 4.

Multivariate survival analysis in classical Hodgkin lymphoma patients

Variable HIV- cHL
HIV- MC subtype
HIV- NS subtype
P HR (95% CI) P HR (95% CI) P HR (95% CI)
Age ≥50 years
<0.001
6.837 (2.588-18.062)
0.009
15.669 (1.995-123.042)
0.915
0.888 (0.099-7.967)
Advanced stage
0.403
1.584 (0.539-4.652)
0.329
2.263 (0.440-11.654)
0.141
3.382 (0.669-17.095)
Bulky disease
0.040
3.822 (1.060-13.783)
0.051
5.146 (0.991-26.725)
0.646
1.732 (0.166-18.091)
Blood monocyte
0.111
0.906 (0.802-1.023)
0.100
0.860 (0.719-1.029)
0.009
0.640 (0.459-0.894)
IDO
0.111
1.018 (0.996-1.040)
0.378
1.011 (0.98601.037)
0.001
1.104 (1.043-1.168)
CD163
0.812
1.002 (0.982-1.023)
0.439
1.008 (0.987-1.030)
0.020
1.061 (1.009-1.116)
CD68 0.636 0.970 (0.854-1.101) 0.906 0.992 (0.872-1.129) 0.735 1.056 (0.772-1.443)

HR, hazard ratio; CI, confidential interval; HIV, human immunodeficiency virus; cHL, classical Hodgkin lymphoma; HR, hazard ratio; CI, confidential interval; IDO, indoleamine 2,3-dioxygenase.

HHS Vulnerability Disclosure